ATNM · Actinium Pharmaceuticals, Inc. · Analyst Estimates
Market Cap
$38.67M
Shares
31.44M
Analyst Estimates
Compare analyst forecasts for Actinium Pharmaceuticals, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1388320
CUSIP
00507W206
13F (30d)
30 filings
30 filers
Visit website
Investor relations